[1]
|
Cefalu, W.T., Xu, D., Long, J., Shi, Y., Zhang, L., Wang, H., Levin, A. and Zhao, M.-H. (2016) Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections from a Diabetes Care Editors’ Expert Forum. Diabetes Care, 39, 1186-1201. https://doi.org/10.2337/dc16-0873
|
[2]
|
Huang, Y.M., et al. (2019) Spectrum of Chronic Kidney Disease in China: A National Study Based on Hospitalized Patients from 2010 to 2015. Nephrology, 24, 725-736. https://doi.org/10.1111/nep.13489
|
[3]
|
Sagoo, M. and Gnudi, L. (2020) Diabetic Nephropathy: An Overview. In: Gnudi, L. and Long, D., Eds., Diabetic Nephropathy, Methods in Molecular Biology, Vol. 2067, Humana, New York, 3-7.
https://doi.org/10.1007/978-1-4939-9841-8_1
|
[4]
|
Winiarska, A., et al. (2021) Inflammation and Oxidative Stress in Diabetic Kidney Disease: The Targets for SGLT2 Inhibitors and GLP-1 Receptor Agonists. 22, Article 10822. https://doi.org/10.3390/ijms221910822
|
[5]
|
Liu, Y., Uruno, A., Saito, R., Matsukawa, N., Hishinuma, E., Saigusa, D., Liu, H. and Yamamoto, M. (2022) Nrf2 Deficiency Deteriorates Diabetic Kidney Disease in Akita Model Mice. Redox Biology, 58, Article ID: 102525.
https://doi.org/10.1016/j.redox.2022.102525
|
[6]
|
Ren, H., Shao, Y., Wu, C., Ma, X., Lv, C. and Wang, Q. (2020) Metformin Alleviates Oxidative Stress and Enhances Autophagy in Diabetic Kidney Disease via AMPK/SIRT1-FoxO1 Pathway. Molecular and Cellular Endocrinology, 500, Article ID: 110628. https://doi.org/10.1016/j.mce.2019.110628
|
[7]
|
Zheng, W., Guo, J. and Liu, Z.S. (2021) Effects of Metabolic Memory on Inflammation and Fibrosis Associated with Diabetic Kidney Disease: An Epigenetic Perspective. Clinical Epigenetics, 13, Article No. 87.
https://doi.org/10.1186/s13148-021-01079-5
|
[8]
|
Hojs, R., Ekart, R., Bevc, S. and Hojs, N. (2016) Markers of In-flammation and Oxidative Stress in the Development and Progression of Renal Disease in Diabetic Patients. Nephron, 133, 159-162. https://doi.org/10.1159/000447434
|
[9]
|
Tian, S. and Chen, S.Y. (2015) Macrophage Polarization in Kidney Diseases. Macrophage, 2, e679.
|
[10]
|
Niewczas, M.A., et al. (2019) A Signature of Circulating Inflammatory Proteins and Development of End-Stage Renal Disease in Diabetes. Nature Medicine, 25, 805-813. https://doi.org/10.1038/s41591-019-0415-5
|
[11]
|
Dong, Y., et al. (2019) High-Sensitivity C Reactive Protein and Risk of Cardiovascular Disease in China—CVD Study. Journal of Epidemiology & Community Health, 73, 188-192. https://doi.org/10.1136/jech-2018-211433
|
[12]
|
Hermans, M.P., Ahn, S.A. and Rousseau, M.F. (2019) Increased CRP: An Extended Biomarker of Microvascular Risk in Men with Type 2 Diabetes. Journal of Diabetes and its Com-plications, 33, Article ID: 107413.
https://doi.org/10.1016/j.jdiacomp.2019.107413
|
[13]
|
Kugler, E., et al. (2015) C Reactive Protein and Long-Term Risk for Chronic Kidney Disease: A Historical Prospective Study. Journal of Nephrology, 28, 321-327. https://doi.org/10.1007/s40620-014-0116-6
|
[14]
|
Ren, H., Wu, C., Shao, Y., Liu, S., Zhou, Y. and Wang, Q. (2020) Correlation between Serum miR-154-5p and Urinary Albumin Excretion Rates in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Cohort Study. Frontiers of Medicine, 14, 642-650. https://doi.org/10.1007/s11684-019-0719-3
|
[15]
|
Mc Causland, F.R., et al. (2016) C-Reactive Protein and Risk of ESRD: Results From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT). American Journal of Kidney Diseases, 68, 873-881.
https://doi.org/10.1053/j.ajkd.2016.07.022
|
[16]
|
Shankar, A., et al. (2011) Markers of Inflammation Predict the Long-Term Risk of Developing Chronic Kidney Disease: A Population-Based Cohort Study. Kidney International, 80, 1231-1238. https://doi.org/10.1038/ki.2011.283
|
[17]
|
Cao, L., et al. (2019) Inflammation and Kidney Injury in Dia-betic African American Men. Journal of Diabetes Research, 2019, Article ID: 5359635. https://doi.org/10.1155/2019/5359635
|
[18]
|
Luo, F., et al. (2021) Systemic Immune-Inflammation Index Predicts the Outcome after Aneurysmal Subarachnoid hemorrhage. (Preprint) https://doi.org/10.21203/rs.3.rs-687534/v1
|
[19]
|
Microvascular Complications Group of Chinese Diabetes (2021) [Clinical Guideline for the Prevention and Treatment of Diabetic Kidney Disease in China (2021 Edition)]. Chinese Journal of Diabetes Mellitus, 13, 762-784. (In Chinese)
|
[20]
|
Sudchada, P. and Laehn, S. (2016) Comparisons of GFR Estimation Using the CKD Epidemiology Collaboration (CKD-EPI) Equation and other Creatinine-Based Equations in Asian Population: A Systematic Review. International Urology and Nephrology, 48, 1511-1517. https://doi.org/10.1007/s11255-016-1357-1
|
[21]
|
Navarro-González, J.F., et al. (2011) Inflammatory Molecules and Pathways in the Pathogenesis of Diabetic Nephropathy. Nature Reviews Nephrology, 7, 327-340. https://doi.org/10.1038/nrneph.2011.51
|
[22]
|
Pérez-Morales, R.E., et al. (2019) Inflammation in Diabetic Kidney Disease. Nephron, 143, 12-16.
https://doi.org/10.1159/000493278
|
[23]
|
Chow, F.Y., et al. (2005) Intercellular Adhesion Molecule-1 Deficiency Is Protective against Nephropathy in Type 2 Diabetic db/db Mice. Journal of the American Society of Nephrology, 16, 1711-1722.
https://doi.org/10.1681/ASN.2004070612
|
[24]
|
Choudhary, N. and Ahlawat, R.S. (2008) Interleukin-6 and C-Reactive Protein in Pathogenesis of Diabetic Nephropathy: New Evidence Linking Inflammation, Glycemic Control and Microalbuminuria. Iran J Kidney Dis, 2, 72-79.
|
[25]
|
Zhou, Y., et al. (2019) Expression of Urokinase-Type Plas-minogen Activator Receptor and Its Soluble Form in Type 2 Diabetic Kidney Disease. Archives of Medical Research, 50, 249-256. https://doi.org/10.1016/j.arcmed.2019.08.007
|
[26]
|
Gu, H., et al. (2012) Association of Intercellular Ad-hesion Molecule 1 (ICAM1) with Diabetes and Diabetic Nephropathy. Frontiers in Endocrinology, 3, Article 179. https://doi.org/10.3389/fendo.2012.00179
|
[27]
|
Sanchez-Alamo, B., et al. (2022) Serum Interleukin-6 Levels Pre-dict Kidney Disease Progression in Diabetic Nephropathy. Clinical Nephrology, 97, 1-9. https://doi.org/10.5414/CN110223
|
[28]
|
Al-Rubeaan, K., Nawaz, S.S., Youssef, A.M., Al Ghonaim, M. and Sid-diqui, K. (2019) IL-18, VCAM-1 and P-selectin as Early Biomarkers in Normoalbuminuric Type 2 Diabetes Patients. Future Medicine, 13, 467-478.
https://doi.org/10.2217/bmm-2018-0359
|
[29]
|
Zhong, Y., et al. (2019) Arctigenin Attenuates Diabetic Kidney Dis-ease through the Activation of PP2A in Podocytes. Nature Communications, 10, Article No. 4523. https://doi.org/10.1038/s41467-019-12433-w
|
[30]
|
Das, N.A., et al. (2020) Empagliflozin Reduces High Glu-cose-Induced Oxidative Stress and miR-21-Dependent TRAF3IP2 Induction and RECK Suppression and Inhibits Hu-man Renal Proximal Tubular Epithelial Cell Migration and Epithelial-to-Mesenchymal Transition. Cellular Signalling, 68, Article ID: 109506.
https://doi.org/10.1016/j.cellsig.2019.109506
|
[31]
|
Du Clos, T.W. and Mold, C. (2004) C-Reactive Protein: An Ac-tivator of Innate Immunity and a Modulator of Adaptive Immunity. Immunologic Research, 30, 261-277. https://doi.org/10.1385/IR:30:3:261
|
[32]
|
Krychtiuk, K.A., Kastl, S.P., Speidl, W.S. and Wojta, J. (2013) Inflamma-tion and Coagulation in Atherosclerosis. Hamostaseologie, 33, 269-282. https://doi.org/10.5482/HAMO-13-07-0039
|
[33]
|
Wang, L.-K., Wang, H., Wu, X.-L., Shi, L., Yang, R.-M. and Wang, Y.-C. (2020) Relationships among Resistin, Adiponectin and Leptin and Microvascular Complications in Patients with Type 2 Diabetes Mellitus. Journal of International Medical Research, 48. https://doi.org/10.1177/0300060519870407
|
[34]
|
You, Y.K., Wu, W.-F., Huang, X.-R., Li, H.-D., Ren, Y.-P., Zeng, J.-C. Chen, H. and Lan, H.Y. (2021) Deletion of Smad3 Protects against C-Reactive Protein-Induced Renal Fibro-sis and Inflammation in Obstructive Nephropathy. International Journal of Biological Sciences, 17, 3911-3922. https://doi.org/10.7150/ijbs.62929
|
[35]
|
Pawluczyk, I.Z., Yang, B., Patel, S.R., Saleem, M.A. and Topham, P.S. (2011) Low-Level C-Reactive Protein Levels Exert Cytoprotective Actions on Human Podocytes. Nephrology Dialysis Transplantation, 26, 2465-2475.
https://doi.org/10.1093/ndt/gfq830
|